Korean J Pediatr Hematol Oncol.  2003 Apr;10(1):126-130.

A Case of Protein S Deficiency with Cerebral Infarction

Affiliations
  • 1Department of Pediatrics, Kyungpook National University School of Medicine, Daegu, Korea. kslee@knu.ac.kr

Abstract

Certain natural anticoagulants are known to play critical roles on the control of hemostasis in addition to the physiologic role of fibrinolysis. Major antiproteases of this group include antithrombin III, protein C, protein S, alpha-2-antiplasmin, alpha-2-macroglobulin, etc. There has been increasing recognition of the importance of the control of coagulation and fibrinolysis, both by certain physiologic processes and by natural inhibitors. Especially, activated protein C (protein Ca) and its cofactor, protein S, now are recognized as significant modulators of fibrinolysis, thrombosis and hemostasis. Children and adults with decreased levels of either protein are at increased risk from thrombosis. We experienced a 5 year-old girl patient with cerebral infarction who initially presented with abnormal movement of left extremities. She had lacunar infarction in the posterior limb of the right internal capsule and hypoplastic left carotid artery on brain MRI and MR angiography. She was diagnosed to have protein S deficiency with the level of 43% in the screening test of hypercoagulable state. She remains clinically well after heparin and warfarin treatment with regular follow-up of prothrombin time. A brief review of the literature ensues with the case report.

Keyword

Cerebral infarction; Protein S deficiency; Warfarin; Low-molecular-weight-heparin

MeSH Terms

Adult
alpha-2-Antiplasmin
Angiography
Anticoagulants
Antithrombin III
Brain
Carotid Arteries
Cerebral Infarction*
Child
Child, Preschool
Dyskinesias
Extremities
Female
Fibrinolysis
Follow-Up Studies
Hemostasis
Heparin
Humans
Internal Capsule
Magnetic Resonance Imaging
Mass Screening
Protease Inhibitors
Protein C
Protein S Deficiency*
Protein S*
Prothrombin Time
Stroke, Lacunar
Thrombosis
Warfarin
Anticoagulants
Antithrombin III
Heparin
Protease Inhibitors
Protein C
Protein S
Warfarin
alpha-2-Antiplasmin
Full Text Links
  • KJPHO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr